Biogen
BIIB
BIIB
870 hedge funds and large institutions have $20.2B invested in Biogen in 2024 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 298 increasing their positions, 321 reducing their positions, and 158 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
18% less first-time investments, than exits
New positions opened: 130 | Existing positions closed: 158
19% less capital invested
Capital invested by funds: $25.1B → $20.2B (-$4.83B)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
870
Holding in Top 10
5
Calls
$310M
Puts
$356M
Top Buyers
| 1 | +$447M | |
| 2 | +$198M | |
| 3 | +$163M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$125M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$91.9M |
Top Sellers
| 1 | -$533M | |
| 2 | -$230M | |
| 3 | -$195M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$170M |
| 5 |
ClearBridge Investments
New York
|
-$101M |